tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Neurotech Seeks ASX Quotation for 246.7 Million New Shares

Story Highlights
  • Neurotech International is applying to list 246.7 million new ordinary shares on the ASX.
  • The sizeable share issue will expand Neurotech’s capital base and may impact liquidity and shareholder positions.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Neurotech Seeks ASX Quotation for 246.7 Million New Shares

Claim 70% Off TipRanks Premium

An announcement from Neurotech International ( (AU:NTI) ) is now available.

Neurotech International has applied to the ASX for quotation of 246.7 million new ordinary fully paid shares, expanding its listed securities on the Australian market. The issuance, lodged via an Appendix 2A application and tied to previously flagged transactions, significantly increases the company’s share count and is likely to affect its capital structure and liquidity profile for existing and prospective shareholders.

More about Neurotech International

Average Trading Volume: 1,253,685

Technical Sentiment Signal: Sell

Current Market Cap: A$17.84M

See more data about NTI stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1